Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05531240 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 2023 to Dec 2027v4 Show 5 more changesShow less
    • Study completion date: Dec 2025 to Dec 2029
    • Start date changed from estimate of Oct 2022 to Oct 1, 2022
    • Eligibility criteria expanded, about 9 words
    • Collaborators revised (4)
    • Publications: 11 to 5
  2. Secondary endpoints revised (4)v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised at 4 of 4 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study focuses on the treatment of benign prostatic hyperplasia which causes lower urinary tract symptoms. The purpose of the research project is to evaluate PAE in terms of both medical and health economic outcomes. To evaluate whether there are any differences in effect (IPSS), complications, costs and perceived quality of life compared with TUR-P.
Trial Details
NCT Number NCT05531240
Lead Sponsor Uppsala University
Collaborators: Centrallasarettet Västerås, Lasarettet i Enköping, Sormland County Council, Sweden, Region Stockholm
Conditions
(from sponsor)		 Transurethral Resection of Prostate Syndrome, Prostate Hyperplasia, Embolization, Therapeutic
Related terms Prostatic Hyperplasia
Enrollment 104 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov